Scleroderma renal crisis and renal involvement in systemic sclerosis.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. Advances in hematopoietic stem cell transplantation for autoimmune diseases.Heliyon · 2024
   Review
2. Paclitaxel-induced diffuse scleroderma with possible scleroderma-renal crisis: a case report and literature review of taxanes-induced scleroderma.Clinical rheumatology · 2022
   Review
3. New Era in Systemic Sclerosis Treatment: Recently Approved Therapeutics.Journal of clinical medicine · 2022
   Review
4. Scleroderma renal crisis: Case reports and update on critical issues.European journal of rheumatology · 2021
   Article
5. Endothelial-to-mesenchymal transition in systemic sclerosis.Clinical and experimental immunology · 2021
   Review
6. Modulation of microRNome by Human Cytomegalovirus and Human Herpesvirus 6 Infection in Human Dermal Fibroblasts: Possible Significance in the Induction of Fibrosis in Systemic Sclerosis.Cells · 2021
   Article
7. C5 Inhibition in Secondary Thrombotic Microangiopathies: A Yet Unresolved Question.Kidney international reports · 2021
   Article
8. Scleroderma renal crisis: a review for emergency physicians.Internal and emergency medicine · 2019
   Review
9. Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling.Scientific reports · 2019
   Article

Corrections and comments

• Erratum for
  Scleroderma renal crisis and renal involvement in systemic sclerosis.2016

Authors and funding

5 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract